New Jersey
Civil Justice Institute

  • Helpful Links
  • Contact Us
  • HOME
  • ABOUT US
    • Our Mission
    • Membership
    • Our Staff
  • ISSUES & ADVOCACY
  • OUR WORK IN THE COURTS
  • NEWSROOM
  • GET INVOLVED

Fairness. Justice.
Rule of Law.

Top News Clips for December 9-15

December 15, 2017News, Recent NewsEmployment Law, Expert Evidence, Medical Liability, New Jersey Courts, New Jersey Supreme CourtNJCJI

A selection of the need-to-know civil justice news for December 9-15.

 

Murphy Picks Bergen County Prosecutor Gurbir Grewal for Attorney General

Nicholas Pugliese | NorthJersey.com

Gov.-elect Phil Murphy on Tuesday announced the Bergen County prosecutor as his nominee for state attorney general and vowed that his pick will lead the fight against the Trump administration on issues ranging from health care to voting rights and the environment.

Read more.

 

 

NJ Justices Say Conference Needed Over Med Mal Testimony

Jeannie O’Sullivan | Law360

The New Jersey Supreme Court reinstated a medical malpractice lawsuit against Newark Beth Israel Medical Center that had been tossed over the late submission of an expert witness’ statement, ruling on Thursday that the parties had been entitled by law to a conference to discuss any concerns about the testimony.

Read more.

 

 

NJ Justices Nix Worker’s Contract Barring 3rd-Party Suits

Jeannie O’Sullivan | Law360

The New Jersey Supreme Court on Monday ruled that an employment contract barring third-party lawsuits wasn’t enforceable under the state’s workers’ compensation law because it contravenes public policy, but a trial court must still determine if the suing employee was partially liable for the injury that prompted his suit.

Read more.

 

 

NJ High Court OKs Roche’s Bids To Review Accutane Rulings

Bill Wichert | Law360

Hoffmann-La Roche Ltd. has convinced the New Jersey Supreme Court to review two state appellate decisions related to the company’s acne medication Accutane, with the justices agreeing to consider rulings over the adequacy of the drug’s label and the admissibility of expert testimony.

Read more.

 

 

Follow @NJCivilJustice on Twitter for even more news. 

 

Newsletter Sign Up




© 2022 NJCJI. All rights reserved.

Follow us on:

  • twitter
  • linkedin

TWITTER FEED TWITTER FEED

  • https://t.co/DlWbCRFBea, Jul 1
  • https://t.co/xl0stnCZfj NJCJI President Anthony Anastasio testified this week about the implications of NJ Senate… https://t.co/o55d5pA29b, Jun 24
  • https://t.co/x2z9vrW707 Thank you to @PPAGInc, @GenovaBurns, and @PBWTLaw for your support of the 2022 Spring Event!, Jun 21
  • Institute for Legal Reform Releases Update on Third-Party Litigation Funding https://t.co/UQDqeUQ712, Apr 15
  • The American Tort Reform Association issued a report about the National Association of Attorneys General. https://t.co/14sYVCKPrY, Apr 8

    QUICK CONTACT



    Please enter the code as shown below

    captcha

    New Jersey Civil Justice Institute | 112 West State Street, Trenton, NJ 08608 | office: (609) 218-6331 | info@civiljusticenj.org